Coronary revascularization for patients with unprotected left main coronary artery disease: Evidence, guidelines, and judgment! making clinical decisions in 2009

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 3, 2009, Pages 448-458

  Moussa, Issam D ^a   Wong, S Chiu ^a   Feldman, Ted ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b EVANSTON HOSPITAL   (United States)

Author keywords

Bypass grafts coronary; GRFT; Left main coronary disease; LMCD; PCI; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL;

CLINICAL DECISION MAKING; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INDIVIDUALIZATION; INFORMED CONSENT; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; REOPERATION; REVIEW; STENT THROMBOSIS; STROKE; SURVIVAL RATE; TREATMENT INDICATION; AGED; ANGIOCARDIOGRAPHY; CLINICAL COMPETENCE; INSTRUMENTATION; MALE; MIDDLE AGED; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REGISTER; RISK ASSESSMENT; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL COMPETENCE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350501476     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22088     Document Type: Review

References (30)

1. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. J Am Coll Cardiol 2004;44:e213-e310.
2. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. J Am Coll Cardiol 2006;47:216-235.
3. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. J Am Coll Cardiol 2008;51:172-209.
4. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2009;53:530-553.
5. Taggart DP, Kaul S, Boden We, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol 2008;51:885-892. (Pubitemid 351291667)
6. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the CASS Trialists Collaboration. Lancet 1994;344:563-570. (Pubitemid 24267213)
7. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease: Long-term CASS experience. Circulation 1995;91:2335-2344.
8. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: Initial results from a multicenter registry analysis 1994-1996. Circulation 1997;96:3867-3872.
9. Tamburino C, Di Salvo ME, Capodanno D, et al. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. Am J Cardiol 2009;103:187-193.
10. Erglis A, Narbute I, Kumsars I, et al. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary stenosis. J Am Coll Cardiol 2007;50:491-497. (Pubitemid 47126783)
11. Price MJ, Cristea E, Sawhney N, et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 2006;47:871-877. (Pubitemid 43243114)
12. Chieffo A, Park SJ, Valgimigli M, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: A multicenter registry. Circulation 2007;116:158-162. (Pubitemid 47057521)
13. Sanmartin M, Baz JA, Lozano I, et al. One-Year results of unprotected left main disease treatment with paclitaxel-eluting stents: Results of a multicenter registry. Catheter Cardiovasc Interv 2007;69:372-377. (Pubitemid 46339278)
14. Meliga E, Garcia-Garcia HM, Valgimigli M, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease. The DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008;51:2212-2219. (Pubitemid 351754998)
15. Mehilli J, kastrati A, Schornig A et al. Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for Unprotected Coronary Left Main Lesions (Abstract). ISAR-Left Main. In: TCT Meeting, Washington, DC; 2008.
16. Chieffo A, Morici N, Maisano F. Percutaneous treatment with drugeluting stent implantation versus bypass surgery for unprotected left main stenosis. A single center experience. Circulation 2006;113:2542-2547. (Pubitemid 43948033)
17. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna registry). Am J Cardiol 2006;98:54-59. (Pubitemid 43902697)
18. Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870. (Pubitemid 43243113)
19. Sanmartin M, Baz JA, Claro R, et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 2007;100:970-973. (Pubitemid 47371225)
20. Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-1792. (Pubitemid 351581190)
21. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008;51:538-545. (Pubitemid 351146684)
22. Serruys PW, Morice MC, Kappetein AP, et al.; for the SYNTAX Investigators. PCI versus CABG for severe coronary artery disease. New Engl J Med 2009;360:961-972.
23. Serruys PW for the SYNTAX Investigators. PCI versus CABG for severe coronary artery disease. Subset of patients with unprotected left main coronary artery disease (Abstract). In: TCT Meeting, Washington, DC; 2008.
24. Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118:1146-1154.
25. Chieffo A, Park SJ, Meliga E, et al. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: A multicentre registry. Eur Heart J, 2008 June 18. [Epub ahead of print]
26. Brown PP, Kugelmass AD, Cohen DJ, et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: Results from the United States Medicare Program. Ann Thorac Surg 2008;85:1980-1987.
27. Mathew JP, Fontes ML, Tudor IC, et al. Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-1729.
28. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996;335:1857-1863.
29. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001;344:395-402. (Pubitemid 32128671)
30. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: A randomized controlled trial. JAMA 2005;294:2446-2454. (Pubitemid 41627922)